Alan Evans

4.7k total citations · 1 hit paper
49 papers, 2.6k citations indexed

About

Alan Evans is a scholar working on Oncology, Dermatology and Molecular Biology. According to data from OpenAlex, Alan Evans has authored 49 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 17 papers in Dermatology and 15 papers in Molecular Biology. Recurrent topics in Alan Evans's work include Cutaneous Melanoma Detection and Management (11 papers), Infectious Diseases and Mycology (6 papers) and Melanoma and MAPK Pathways (5 papers). Alan Evans is often cited by papers focused on Cutaneous Melanoma Detection and Management (11 papers), Infectious Diseases and Mycology (6 papers) and Melanoma and MAPK Pathways (5 papers). Alan Evans collaborates with scholars based in United Kingdom, United States and Germany. Alan Evans's co-authors include W.H. Irwin McLean, Aileen Sandilands, Frances J.D. Smith, Robert Dawe, Haihui Liao, Sally H. Ibbotson, James Ferguson, Gehan Arseculeratne, Sherri J. Bale and R.M. MACKIE and has published in prestigious journals such as The Lancet, Nature Genetics and PLoS ONE.

In The Last Decade

Alan Evans

47 papers receiving 2.5k citations

Hit Papers

Loss-of-function mutations in the gene encoding filaggrin... 2006 2026 2012 2019 2006 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Evans United Kingdom 25 1.3k 833 704 547 434 49 2.6k
K. Neuber Germany 26 650 0.5× 558 0.7× 452 0.6× 465 0.9× 273 0.6× 60 1.8k
Véronique Bataille United Kingdom 31 949 0.7× 1.3k 1.5× 130 0.2× 737 1.3× 287 0.7× 68 2.5k
Karen Blessing United Kingdom 26 433 0.3× 995 1.2× 130 0.2× 595 1.1× 667 1.5× 71 2.1k
Toyoko Kikuchi United States 25 1.7k 1.3× 625 0.8× 377 0.5× 587 1.1× 189 0.4× 34 4.2k
Michael S. Vincent United States 30 487 0.4× 432 0.5× 201 0.3× 356 0.7× 364 0.8× 75 2.9k
Wolfgang Dummer United States 29 581 0.4× 891 1.1× 194 0.3× 451 0.8× 283 0.7× 56 3.9k
Omar Duramad United States 14 395 0.3× 300 0.4× 431 0.6× 605 1.1× 280 0.6× 19 3.2k
Leslie M. McEvoy United States 17 364 0.3× 557 0.7× 532 0.8× 360 0.7× 139 0.3× 19 2.3k
Tamara Kopp Austria 25 804 0.6× 270 0.3× 627 0.9× 336 0.6× 107 0.2× 38 2.1k
Giovanni Paolino Italy 21 581 0.4× 444 0.5× 78 0.1× 389 0.7× 406 0.9× 157 1.7k

Countries citing papers authored by Alan Evans

Since Specialization
Citations

This map shows the geographic impact of Alan Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Evans more than expected).

Fields of papers citing papers by Alan Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Evans. The network helps show where Alan Evans may publish in the future.

Co-authorship network of co-authors of Alan Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Evans. A scholar is included among the top collaborators of Alan Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Evans. Alan Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saldanha, Gerald, Peter Colloby, Paul Craig, et al.. (2019). Global and mitosis‐specific interobserver variation in mitotic count scoring and implications for malignant melanoma staging. Histopathology. 76(6). 803–813. 7 indexed citations
2.
Evans, Alan, et al.. (2011). Giant cell arteritis—an incidental finding. British Journal of Oral and Maxillofacial Surgery. 50(1). e9–e10.
3.
Saunders, Sarah, et al.. (2010). Nonpigmented Intradermal Malignant Melanoma With Cribiform, Myxoid, and Spindle Cell Growth Patterns. American Journal of Dermatopathology. 32(8). 829–831. 4 indexed citations
4.
Romanowska, Małgorzata, et al.. (2009). Wnt5a Exhibits Layer-Specific Expression in Adult Skin, Is Upregulated in Psoriasis, and Synergizes with Type 1 Interferon. PLoS ONE. 4(4). e5354–e5354. 55 indexed citations
6.
MACKIE, R.M., Caroline A. Bray, J.P. VESTEY, et al.. (2007). Melanoma incidence and mortality in Scotland 1979–2003. British Journal of Cancer. 96(11). 1772–1777. 86 indexed citations
7.
Evans, Alan, et al.. (2005). Vulval sarcoid: A systemic presentation of sarcoidosis. Journal of Obstetrics and Gynaecology. 25(7). 730–732. 8 indexed citations
8.
McIntyre, P. G., et al.. (2005). Human sealpox resulting from a seal bite: confirmation that sealpox virus is zoonotic. British Journal of Dermatology. 152(4). 791–793. 48 indexed citations
9.
Fleming, Colin, Alyson Bryden, Alan Evans, Robert Dawe, & Sally H. Ibbotson. (2004). A pilot study of treatment of lentigo maligna with 5% imiquimod cream. British Journal of Dermatology. 151(2). 485–488. 79 indexed citations
10.
Smith, Gillian, C. Roland Wolf, Yusuf Deeni, et al.. (2003). Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases. The Lancet. 361(9366). 1336–1343. 113 indexed citations
11.
MacKie, Rona M., Caroline A. Bray, David Hole, et al.. (2002). Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. The Lancet. 360(9333). 587–591. 167 indexed citations
12.
Clark, Colin, et al.. (2000). Narrowband TL-01 Phototherapy for Patch-Stage Mycosis Fungoides. Archives of Dermatology. 136(6). 748–52. 88 indexed citations
13.
Evans, Alan, et al.. (1998). Drug resistance in ovarian cancer — the role of p53. Pathology & Oncology Research. 4(2). 97–102. 33 indexed citations
14.
MACKIE, R.M., D. Hole, John Hunter, et al.. (1997). Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. PubMed Central. 315(7116). 1117–1121. 124 indexed citations
15.
Evans, Alan, et al.. (1995). Metastasising eccrine syringomatous carcinoma. Histopathology. 26(2). 185–187. 10 indexed citations
16.
Sanders, D. S. A., Alan Evans, Gary D. Johnson, et al.. (1994). Classification of CEA‐related positivity in primary and metastatic malignant melanoma. The Journal of Pathology. 172(4). 343–348. 19 indexed citations
17.
Collins, Paul M., et al.. (1994). Pulmonary sarcoidosis presenting as a granulomatous tattoo reaction. British Journal of Dermatology. 130(5). 658–662. 43 indexed citations
18.
MACKIE, R.M., T Aitchison, John Hunter, et al.. (1992). Cutaneous malignant melanoma, Scotland, 1979-89. The Lancet. 339(8799). 971–975. 132 indexed citations
20.
Parks, Dale A., et al.. (1990). Uric acid: Physiologic antioxidant and xanthine oxidase inhibitor. Free Radical Biology and Medicine. 9. 99–99. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026